Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local tissue inflammation mediators are a diverse group of molecules produced at sites of tissue injury or infection that orchestrate the inflammatory response. These mediators are released by various cells, including leukocytes, macrophages, endothelial cells, and platelets, as well as from plasma-derived systems. They act through specific receptors to induce vasodilation, increased vascular permeability, chemotaxis, pain, and leukocyte activation, ultimately contributing to the signs and symptoms of inflammation. Dysregulation of these mediators underlies many chronic diseases.
Varies depending on the specific mediator and drug. Examples include: Inhibition of prostaglandin synthesis (NSAIDs); suppression of cytokine production (corticosteroids); blocking histamine receptors (antihistamines); neutralizing TNF-alpha (anti-TNF agents); blocking leukotriene receptors or synthesis (leukotriene inhibitors).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Local Tissue Inflammation Mediators (NA).